Blaze Bioscience, Inc. — Form D/A

Blaze Bioscience, Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2015-06-25. The offering totals $15.0M, of which $9.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
James M OlsonDirectorSeattle, WA
Dennis M MillerExecutive OfficerSeattle, WA
Julia C NovakExecutive OfficerSeattle, WA
Heather L FranklinDirectorSeattle, WA
Steven R DalyDirectorSeattle, WA
Steven R DalyExecutive OfficerSeattle, WA
Lawrence Patrick HughesDirectorSeattle, WA
James C TowneDirectorSeattle, WA
James C TowneExecutive OfficerSeattle, WA
Ludmila R LobanovaExecutive OfficerSeattle, WA
Jan K OhrstromDirectorSeattle, WA
James OlsonDirectorSt. Petersburg, FL
Claudia Koch JochheimExecutive OfficerSeattle, WA
Jan Koch OhrstromDirectorSeattle, WA
Dennis Cameron MillerExecutive OfficerSeattle, WA
Mary Ellen HughesDirectorSeattle, WA
Ludmila Cameron LobanovaExecutive OfficerSeattle, WA
Heather FranklinDirectorSeattle, WA
Heather FranklinExecutive OfficerSeattle, WA
James Cameron TowneDirectorSeattle, WA
JAN ELLEN OHRSTROMDirectorSEATTLE, WA
CLAUDIA ELLEN JOCHHEIMExecutive OfficerSEATTLE, WA
DENNIS C MILLERExecutive OfficerSEATTLE, WA
LUDMILA C LOBANOVAExecutive OfficerSEATTLE, WA
Julia NovakExecutive OfficerSeattle, WA

Other filings by this issuer (14)

FiledFormOfferingSold
2024-10-21D$20.0M$8.1M
2024-10-21D$25.0M$25.0M
2024-10-21D$15.0M$15.0M
2024-10-21D$10.0M$10.0M
2020-04-08D/A$25.2M$20.2M
2019-02-14D$20.2M$5.0M
2018-05-15D$5.0M$3.0M
2017-10-10D$18.1M$16.1M
2017-06-22D$5.0M$554K
2016-01-12D$5.0M$991K
2014-06-26D/A$15.0M$9.6M
2013-06-27D$15.0M$8.1M
2012-06-19D$10.7M$6.4M
2011-10-17D$1.5M$725K

More